Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongchen Pei

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|March 18, 2022
Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial CarcinomaChaojie Xu, Dongchen Pei, Yi Liu, et al.
Frontiers in Oncology|June 1, 2023
Clinical characteristics and prostate-cancer-specific mortality of competitive risk nomogram in the second primary prostate cancerChaojie Xu, Dongchen Pei, Yi Liu, et al.
Frontiers in Oncology|July 6, 2023
Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscapeAnkang Zhu, Dongchen Pei, Yan Zong, et al.
Frontiers in Oncology|July 21, 2022
A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell CarcinomaDongchen Pei, Chaojie Xu, Dong Wang, et al.
Journal of Oncology|March 14, 2022
Application of m<sup>6</sup>A and TME in Predicting the Prognosis and Treatment of Clear Cell Renal Cell CarcinomaDongchen Pei, Chaojie Xu, Dong Wang, et al.
Frontiers in Molecular Biosciences|August 8, 2022
Clinical Eosinophil-Associated Genes can Serve as a Reliable Predictor of Bladder Urothelial CancerChaojie Xu, Lishan Song, Hui Peng, et al.
International Journal of Surgery (London, England)|February 4, 2025
Innovative logic "AND" gate gene circuits for bladder cancer treatment: preclinical studyChaojie Xu, Ying Dong, Dongchen Pei, et al.
Frontiers in Oncology|August 8, 2022
Clinical M2 Macrophage-Related Genes Can Serve as a Reliable Predictor of Lung AdenocarcinomaChaojie Xu, Lishan Song, Yubin Yang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|March 18, 2022
Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial CarcinomaChaojie Xu, Dongchen Pei, Yi Liu, et al.
Frontiers in Oncology|June 1, 2023
Clinical characteristics and prostate-cancer-specific mortality of competitive risk nomogram in the second primary prostate cancerChaojie Xu, Dongchen Pei, Yi Liu, et al.
Frontiers in Oncology|July 6, 2023
Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscapeAnkang Zhu, Dongchen Pei, Yan Zong, et al.
Frontiers in Oncology|July 21, 2022
A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell CarcinomaDongchen Pei, Chaojie Xu, Dong Wang, et al.
Journal of Oncology|March 14, 2022
Application of m<sup>6</sup>A and TME in Predicting the Prognosis and Treatment of Clear Cell Renal Cell CarcinomaDongchen Pei, Chaojie Xu, Dong Wang, et al.
Frontiers in Molecular Biosciences|August 8, 2022
Clinical Eosinophil-Associated Genes can Serve as a Reliable Predictor of Bladder Urothelial CancerChaojie Xu, Lishan Song, Hui Peng, et al.
International Journal of Surgery (London, England)|February 4, 2025
Innovative logic "AND" gate gene circuits for bladder cancer treatment: preclinical studyChaojie Xu, Ying Dong, Dongchen Pei, et al.
Frontiers in Oncology|August 8, 2022
Clinical M2 Macrophage-Related Genes Can Serve as a Reliable Predictor of Lung AdenocarcinomaChaojie Xu, Lishan Song, Yubin Yang, et al.
Pageof 1